University Institute of Pharmaceutical Sciences (UIPS), Panjab University

What University Institute of Pharmaceutical Sciences (UIPS), Panjab University does

The University Institute of Pharmaceutical Sciences (UIPS) is a department of Panjab University, a public state university established under the Panjab University Act, located in Sector 14, Chandigarh, India. Founded in 1944 in pre-independence Lahore and relocated to Chandigarh following the 1947 partition, UIPS operates with 101–250 employees as a government state entity. Its core offering is a three-tier pharmaceutical education portfolio: a 4-year PCI-approved B.Pharmacy program, M.Pharmacy programs across six disciplines (Pharmaceutical Chemistry, Pharmaceutics, Pharmacognosy, Pharmacology, Pharmaceutical Analysis, and Pharmaceutical Quality Assurance), and doctoral (Ph.D.) research across emerging pharmaceutical sciences. Currently, 227 B.Pharm, 140 M.Pharm, and more than 50 Ph.D. scholars are enrolled.

UIPS runs dedicated research facilities including a Central Animal House with breeding facility, Cell Culture Lab, BSL1 Microbiology Lab, Medicinal Plants Garden, and well-equipped laboratories with advanced instruments. The institute operates under recurring regulatory designations (PCI approvals per academic session, NIRF Rank 2, SAP/DSA, COSIST, CAS, DST-FIST) and uniquely carries the UGC-NRC program — the only pharmacy institute in India with this designation, having trained over 700 pharmacy faculty nationally. Its research output comprises more than 3,500 publications, 63 textbooks, 55 monographs (including 26 in the Ayurvedic Pharmacopoeia of India), 56 granted and 48 filed patent applications, 11 indigenous technologies transferred to industry, and 6 commercialised products in market. Faculty credentials include 8 members listed by Stanford University among the top 2% of global scientists in Pharmacy & Pharmacology, with recognitions spanning Amrut Mody, Ranbaxy, DBT Technology, OPPI, BRICS, US-Fulbright, and Commonwealth awards.

The institute's business model is multi-stream: tuition and academic fees (regular and self-finance tracks across all three programs), government and industry research project funding (ANRF, ICMR, DBT, DST, CSIR, UGC, plus industry sponsors such as IPCA, Kanha Wellness, and BDH Industry), and licensing/royalties via technology transfer of laboratory-developed IP. Professor Ranju Bansal is the current Chairperson, effective June 1, 2026. As a public state entity with no external private equity, venture capital, or shareholding structure, UIPS operates under the governance of Panjab University with no shareholders in the conventional corporate sense.

Name

University Institute of Pharmaceutical Sciences (UIPS), Panjab University

Legal name

University Institute of Pharmaceutical Sciences, Panjab University

Website

https://uips.puchd.ac.in

Company type

Private

Founded year

1944

Operating status

Operating

Headcount range

101–250 employees

Short description

The University Institute of Pharmaceutical Sciences (UIPS) is a department of Panjab University in Chandigarh, India, delivering PCI-approved B.Pharm, M.Pharm (6 disciplines), and Ph.D. programs in pharmaceutical sciences to undergraduate, postgraduate, and doctoral students, with active government and industry-sponsored research and a unique UGC-NRC national pharmacy teacher-training mandate.

Ownership category

akta.pro rank

Product category

Pharmaceutical Education and Research

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYEDAHAGAE

Schools of Pharmacy

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

Keywords

• Pharmaceutical education
• Pharmacy research
• Doctoral programs
• Drug development research
• Technology transfer services

Headquarters

HQ city

Chandigarh

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Tuition and Academic Fees: Revenue from B.Pharmacy, M.Pharmacy programs and Ph.D. programs through student fees (both regular and self-finance courses)
2. Research Project Funding: Government and industry funding for research projects including ANRF, ICMR, DBT, DST, CSIR grants and industry-sponsored projects
3. Technology Transfer: Transfer of indigenous technologies to industry (11 technologies transferred) and commercialized products developed at UIPS

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

University Institute of Pharmaceutical Sciences (UIPS) offers Pharmacy Council of India (PCI)-approved undergraduate (B.Pharmacy, 4-year), postgraduate (M.Pharmacy in 6 disciplines), and doctoral (Ph.D.) programs in pharmaceutical sciences. Beyond education, UIPS conducts pharmaceutical research, discovers new molecules, transfers 11 indigenous technologies to industry, and has commercialized 6 products in the market. The institute also operates the country's only pharmacy-focused UGC-National Resource Centre (NRC) for training pharmacy faculty.

Product overview

UIPS is a premier educational institute offering a comprehensive portfolio of pharmaceutical education programs: a 4-year B.Pharmacy undergraduate program, M.Pharmacy postgraduate programs in 6 specialized disciplines (Pharmaceutical Chemistry, Pharmaceutics, Pharmacognosy, Pharmacology, Pharmaceutical Analysis, and Pharmaceutical Quality Assurance), and doctoral (Ph.D.) research programs across emerging pharmaceutical science areas. The institute also operates the unique UGC-National Resource Centre program and maintains specialized research facilities including Central Animal House, Cell Culture Laboratory, BSL1 Microbiology Laboratory, and Medicinal Plants Garden. The institute's offerings extend beyond education to include technology transfer services, having transferred 11 indigenous technologies to industry and placing 6 products in the market.

Differentiator

Problem solved

Functional benefit

Products and services

• B.Pharmacy (B.Pharm.) Program A 4-year undergraduate pharmacy program approved by the Pharmacy Council of India (PCI) that provides foundational education in pharmaceutical sciences, preparing students for careers in pharma industry, research, and regulation.
• M.Pharmacy (M.Pharm.) Program Postgraduate pharmacy program offered in 6 specialized disciplines (Pharmaceutical Chemistry, Pharmaceutics, Pharmacognosy, Pharmacology, Pharmaceutical Analysis, and Pharmaceutical Quality Assurance) for students seeking advanced specialized knowledge in pharmaceutical sciences.
• Doctor of Philosophy (Ph.D.) Program Doctoral degree program offered in all emerging areas of pharmaceutical sciences for advanced research and academic pursuit, with more than 50 currently registered scholars.
• UGC-National Resource Centre (NRC) Program

Quantifiable outcome

• NIRF Rank 2 in Pharmacy category in India
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• PGIMER Chandigarh (Postgraduate Institute of Medical Education and Research)coreStrategic or Co-development PartnerSynergistic three-tier tie of UIPS-industry-medical institutions with PGIMER Chandigarh, enabling transfer of ideas from laboratory to the market and the clinician's desk through collaborative research and development.
• BDH IndustryminorStrategic or Co-development PartnerIndustry partner for research collaboration on liposome technology platform at nano scale for product development.
• IPCA IndustryminorStrategic or Co-development PartnerFinancial assistance for research and innovation activities at Panjab University (Rs. 25,00,000 for three years from Feb 2024 to Feb 2027).
• Kanha Wellness and Retreat TrustminorStrategic or Co-development PartnerResearch proposal for development of novel formulation for anal fissure, haemorrhoids and related conditions including psoriasis (Rs. 4,41,320 for two years).

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Indian Institute of Technology (IIT) — Department of Pharmaceutical Engineering: Emerging pharmacy-adjacent programmes within premier Indian technical institutes, increasingly competing for pharmaceutical research grants and talented graduates. An adjacent player whose footprint in pharmaceutical sciences research is growing.

Regional players

• Monash University Faculty of Pharmacy and Pharmaceutical Sciences: Top-ranked Australian pharmacy school with substantial industry-sponsored research and technology-transfer infrastructure. Comparable as a reference point for translational research output and global pharmaceutical sciences leadership.
• UCL School of Pharmacy: Leading global pharmacy school offering MPharm, postgraduate, and doctoral programmes. Functions as a relevant international comparison on research excellence and curriculum depth, but operates in a different geography and regulatory framework.

Direct peers

• Manipal College of Pharmacy: Constituent college of MAHE offering B.Pharm, M.Pharm, and doctoral programmes with significant research output and industry-funded projects. Direct competitor for top-tier pharmacy admissions and research funding in India.
• Bombay College of Pharmacy: Autonomous pharmacy institute in Mumbai offering PCI-approved B.Pharm, M.Pharm, and Ph.D. programmes with a heritage comparable to UIPS. Competes for top pharmacy talent and features prominently in NIRF rankings.
• National Institute of Pharmaceutical Education and Research (NIPER), Mohali: India's flagship public pharmaceutical education and research institute located in the same region as UIPS. Directly comparable on PCI-approved programmes (M.Pharm, Ph.D.), funded by the Department of Pharmaceuticals, and competing for top NIRF rankings and government research grants.
• JSS College of Pharmacy, Ooty: A leading Indian pharmacy institution with PCI-approved B.Pharm, M.Pharm, and Ph.D. programmes and strong industry linkages. Comparable in NIRF ranking category, research output scale, and placement record.
• University Institute of Pharmacy, Panjabi University: Another northern-Indian pharmacy institute at a public university with PCI-approved programmes. Comparable on academic structure, public-university funding model, and competition for the regional student pool.
• BITS Pilani — Department of Pharmacy: Pharmacy department within a top-ranked Indian private university offering integrated and doctoral programmes. Comparable in research scale, industry collaborations, and selective admissions, though housed in a private-deemed university structure.

Broad incumbents

• Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh: Premier medical institution and UIPS's strategic partner in the UIPS-industry-medical triangle. While focused on clinical medicine, PGIMER is co-located, shares a research alliance, and competes for adjacent life-sciences funding and faculty talent.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/UIPS-Connect-100040747165467
• LinkedInlinkedin.com/company/uips-pu

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Institute of Pharmaceutical Sciences (UIPS), Panjab University